{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:56:10Z","timestamp":1792007770488,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81302226"],"award-info":[{"award-number":["81302226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Project of the Jilin Province","award":["20130101164JC"],"award-info":[{"award-number":["20130101164JC"]}]},{"name":"the Science and Technology Project of the Jilin Province","award":["20140414059GH"],"award-info":[{"award-number":["20140414059GH"]}]},{"name":"the Science and Technology Project of Jilin Province Education Department","award":["2014200"],"award-info":[{"award-number":["2014200"]}]},{"name":"the Science and Technology Project of Jilin Province Education Department","award":["20132070"],"award-info":[{"award-number":["20132070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12865-016-0174-8","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T11:37:31Z","timestamp":1475494651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis"],"prefix":"10.1186","volume":"17","author":[{"given":"Yanbo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanguo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuowen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weigao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinlong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"174_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","volume":"27","author":"M Ploeg","year":"2009","unstructured":"Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27:289\u201393.","journal-title":"World J Urol"},{"key":"174_CR2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893\u2013917.","journal-title":"Int J Cancer"},{"key":"174_CR3","unstructured":"Howlader N, Noone, AM, Krapcho M. SEER Cancer Statistics Review 1975\u20132010. National Cancer Institute, Bethesda, MD, USA. 2012."},{"key":"174_CR4","first-page":"133","volume":"14","author":"RH Young","year":"1997","unstructured":"Young RH. Pseudoneoplastic lesions of the urinary bladder and urethra: a selective review with emphasis on recent information. Semin Diagn Pathol. 1997;14:133\u201346.","journal-title":"Semin Diagn Pathol"},{"key":"174_CR5","first-page":"67","volume":"37","author":"A Dabrowska","year":"2012","unstructured":"Dabrowska A, Slotwinski R, Kedziora S. Inflammation and cancer-double face of Toll-like receptors. Centr Eur J Immunol. 2012;37:67\u201370.","journal-title":"Centr Eur J Immunol"},{"key":"174_CR6","doi-asserted-by":"crossref","unstructured":"Kim R, Liu W, Chen X, Kreder KJ, Luo Y. Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models. Journal of Biomedicine and Biotechnology. J Biomed Biotechnol. 2011:937061.","DOI":"10.1155\/2011\/937061"},{"key":"174_CR7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"JK Kolls","year":"2004","unstructured":"Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467\u201376.","journal-title":"Immunity"},{"key":"174_CR8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/cr.2007.35","volume":"17","author":"SH Chang","year":"2007","unstructured":"Chang SH, Dong C. A novel heterodimeric cytokine consisting of IL-17 and IL-17\u00a0F regulates inflammatory responses. Cell Res. 2007;17:435\u201340.","journal-title":"Cell Res"},{"key":"174_CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2011.03465.x","volume":"134","author":"R Pappu","year":"2011","unstructured":"Pappu R, Ramirez-Carrozzi V, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology. 2011;134:8\u201316.","journal-title":"Immunology"},{"key":"174_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/pros.22931","volume":"75","author":"A Angulo De","year":"2015","unstructured":"De Angulo A, Faris R, Daniel B, Jolly C, de Graffenried L. Age-related increase in IL-17 activates pro-inflammatory signaling in prostate cells. Prostate. 2015;75:449\u201362.","journal-title":"Prostate"},{"key":"174_CR11","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.cellsig.2013.07.021","volume":"25","author":"X Song","year":"2013","unstructured":"Song X, Qian Y. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases. Cell Signal. 2013;25:2335\u201347.","journal-title":"Cell Signal"},{"key":"174_CR12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ACI.0000000000000133","volume":"15","author":"R Divekar","year":"2015","unstructured":"Divekar R, Kita H. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol. 2015;15:98\u2013103.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"174_CR13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00262-008-0502-9","volume":"57","author":"T Benatar","year":"2008","unstructured":"Benatar T, Cao MY, Lee Y, Li H, Feng N, Gu X, et al. Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors. Cancer Immunol Immunother. 2008;57:1757\u201369.","journal-title":"Cancer Immunol Immunother"},{"key":"174_CR14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1189\/jlb.1105656","volume":"80","author":"C Lamagna","year":"2006","unstructured":"Lamagna C, Aurrand-Lions M, Imhof BA. Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol. 2006;80:705\u201313.","journal-title":"J Leukoc Biol"},{"key":"174_CR15","doi-asserted-by":"crossref","first-page":"e9244","DOI":"10.5812\/ircmj.9244","volume":"17","author":"R Baharlou","year":"2015","unstructured":"Baharlou R, Khezri A, Razmkhah M, Habibagahi M, Hosseini A, Ghaderi A, et al. Increased interleukin-17 transcripts in peripheral blood mononuclear cells, a link between T-helper 17 and proinflammatory responses in bladder cancer. Iran Red Crescent Med J. 2015;17:e9244.","journal-title":"Iran Red Crescent Med J"},{"key":"174_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/fon.12.180","volume":"9","author":"M Doroudchi","year":"2013","unstructured":"Doroudchi M, Saidi M, Malekzadeh M, Golmoghaddam H, Khezri A, Ghaderi A. Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status. Future Oncol. 2013;9:295\u2013304.","journal-title":"Future Oncol"},{"key":"174_CR17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","volume":"206","author":"L Wang","year":"2009","unstructured":"Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med. 2009;206:1457\u201364.","journal-title":"J Exp Med"},{"key":"174_CR18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/eji.201040773","volume":"41","author":"A Takeuchi","year":"2011","unstructured":"Takeuchi A, Dejima T, Hisakata Shibata K, Nakamura R, Eto M, et al. IL-17 production by \u03b3\u03b4 T cells is important for the antitumor effect of Mycobacterium bovisbacillus Calmette-Gu\u00e9rin treatment against bladder cancer. Eur J Immunol. 2011;41:246\u201351.","journal-title":"Eur J Immunol"},{"key":"174_CR19","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/pros.23058","volume":"75","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhao X, Sun X, Li Y, Wang Z, Jiang J, et al. Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia. Prostate. 2015;75:1844\u201356.","journal-title":"Prostate"},{"key":"174_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/jcp.43.1.17","volume":"43","author":"AJ Robertson","year":"1990","unstructured":"Robertson AJ, Beck JS, Burnett RA, Howatson SR, Lee FD, Lessells AM, et al. Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol. 1990;43:17\u201321.","journal-title":"J Clin Pathol"},{"key":"174_CR21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-5347(01)61948-7","volume":"161","author":"PM Hanno","year":"1999","unstructured":"Hanno PM. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health interstitial cystitis database study. J Urol. 1999;161:553\u20137.","journal-title":"J Urol"},{"key":"174_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4110\/in.2014.14.3.156","volume":"14","author":"R Baharlou","year":"2014","unstructured":"Baharlou R, Ahmadi Vasmehjani A, Dehghani A, Ghobadifar MA, Khoubyari M. Reduced interleukin-17 and transforming growth factor Beta levels in peripheral blood as indicators for following the course of bladder cancer. Immune Netw. 2014;14:156\u201363.","journal-title":"Immune Netw"},{"key":"174_CR23","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.juro.2014.04.099","volume":"192","author":"Y Logadottir","year":"2014","unstructured":"Logadottir Y, Delbro D, Fall M, Gjertsson I, Jirholt P, Lindholm C, et al. Cytokine expression in patients with bladder pain syndrome\/interstitial cystitis ESSIC type 3C. J Urol. 2014;192:1564\u20138.","journal-title":"J Urol"},{"key":"174_CR24","doi-asserted-by":"crossref","unstructured":"Rasoul B, Abbas AV, Ali D, Mohamed AG, Mahshid K. Reduced Interleukin-17 and Transforming Growth Factor Beta Levels in Peripheral Blood as Indicators for Following the Course of Bladder Cancer. Immune Netw. 2014;14:156\u201363.","DOI":"10.4110\/in.2014.14.3.156"},{"key":"174_CR25","doi-asserted-by":"crossref","unstructured":"Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. The Journal of Experimental Medicine. 2009;206:1457\u201364.","DOI":"10.1084\/jem.20090207"},{"key":"174_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2014.00131","volume":"5","author":"A Boltjes","year":"2014","unstructured":"Boltjes A, van Wijk F. Human dendritic cell functional specialization in steady-state and inflammation. Front Immunol. 2014;5:131.","journal-title":"Front Immunol"},{"key":"174_CR27","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.167.8.4137","volume":"167","author":"T Starnes","year":"2001","unstructured":"Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, et al. Cutting edge: IL-17\u00a0F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J imunol. 2001;167:4137\u201340.","journal-title":"J imunol"},{"key":"174_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.imlet.2004.11.012","volume":"98","author":"H Takahashi","year":"2005","unstructured":"Takahashi H, Numasaki M, Lotze MT, Sasaki H. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol Lett. 2005;98:189\u201393.","journal-title":"Immunol Lett"},{"key":"174_CR29","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","volume":"101","author":"M Numasaki","year":"2003","unstructured":"Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood. 2003;101:2620\u20137.","journal-title":"Blood"},{"key":"174_CR30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens LM. Macrophages and therapeutic resistance in cancer. Cancer Cell. 2015;27:462\u201372.","journal-title":"Cancer Cell"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-016-0174-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T06:21:25Z","timestamp":1568442085000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-016-0174-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1186\/s12865-016-0174-8","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]},"article-number":"36"}}